Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Merck to acquire Verona Pharma for $10B, gaining Ohtuvayre, a breakthrough COPD treatment with rapid uptake since its 2024 launch.

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Friday, Apr. 2, 2021, in Durham, N.C.·Raleigh News and Observer·Casey Toth/ctoth@newsobserver.com ...

Based in New Jersey, Merck is the world’s 42nd-largest public company by market capitalization. In March, the drugmaker opened a $1 billion vaccine manufacturing facility in north Durham, at its ...

In energy stocks, Enerflex lost 36 cents, or 3.2%, to $11.06, while Paramount Resources gave back 61 cents, or 2.8%, to $21.31. In consumer staples, Alimentation Couche-Tard dipped $1.13, or 1.6%, to ...

The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

Biogen said it intends to invest an additional $2 billion to expand operations at its largest manufacturing facilities within North Carolina’s Research Triangle Park (RTP).